| GKIRX | HBLAX | GKIRX / HBLAX | |
| Total Expense Ratio | 0.56 | 0.89 | 63% |
| Annual Report Gross Expense Ratio | 0.69 | 0.89 | 78% |
| Fund Existence | 16 years | 20 years | - |
| Gain YTD | 6.822 | 4.636 | 147% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | 2000 | - |
| Net Assets | 2.8B | 11.1B | 25% |
| Annual Yield % from dividends | 4.00 | 3.15 | 127% |
| Returns for 1 year | 11.03 | 5.37 | 206% |
| Returns for 3 years | 34.49 | 18.09 | 191% |
| Returns for 5 years | 27.74 | 5.69 | 487% |
| Returns for 10 years | 90.20 | 39.35 | 229% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSEAX | 83.56 | 1.66 | +2.03% |
| Fidelity Emerging Asia | |||
| FEQJX | 15.89 | 0.08 | +0.51% |
| Fidelity Advisor Hedged Equity I | |||
| WSTRX | 64.63 | 0.17 | +0.26% |
| Nomura Science and Technology R | |||
| LVAMX | 11.25 | N/A | N/A |
| LSV US Managed Volatility Investor | |||
| CEIZX | 14.86 | -0.03 | -0.20% |
| Manning & Napier Callodine Equity Inc Z | |||